Top Markets
Coin of the day
BerGenBio ASA BerGenBio ASA

BerGenBio ASA

BGBIO
शेयरों में रैंक #37880
BerGenBio ASA is a biopharmaceutical firm in the clinical development stage,... BerGenBio ASA is a biopharmaceutical firm in the clinical development stage, focused on developing therapies for drug-resistant, immune-evasive, and metastatic cancers, in addition to respiratory conditions. Its leading compound, Bemcentinib, is a bio-available small molecule AXL inhibitor currently in Phase II clinical trials for major cancer indications and COVID-19. The Phase II trial program specifically addresses non-small cell lung cancer, acute myeloid leukemia, myelodysplastic syndrome, and COVID-19. Moreover, the company is progressing tilvestamab, an anti-AXL antibody, through Phase Ib clinical trials. BerGenBio ASA also maintains a collaboration agreement with Merck & Co. for its clinical studies. The company was founded in 2007 and operates from its base in Bergen, Norway.
शेयर मूल्य
$0.051239
अंतिम समन्वयन: 2025-11-24
मार्केट कैप
$1.38M
बदलाव (1 दिन)
-4.48%
बदलाव (1 वर्ष)
-54.57%
देश
NO
व्यापार BerGenBio ASA (BGBIO)

श्रेणी

BerGenBio ASA (BGBIO) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.08 (2025-11-01 को)

दिन का सबसे निम्न समापन मूल्य: $45.81 (2017-04-01 को)
BerGenBio ASA के स्टॉक मूल्य का इतिहास 2017 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) 36.04%
2025 -90.51%
2024 -63.90%
2023 -73.76%
2022 -63.83%
2021 -44.23%
2020 73.06%
2019 -30.98%
2018 -3.30%
2017 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE